Heck Capital Advisors LLC Acquires Shares of 3,260 UnitedHealth Group Incorporated (NYSE:UNH)

Heck Capital Advisors LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,260 shares of the healthcare conglomerate's stock, valued at approximately $1,649,000.

Several other institutional investors have also added to or reduced their stakes in the stock. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $28,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $30,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded down $0.58 during midday trading on Tuesday, hitting $294.99. The company had a trading volume of 20,069,744 shares, compared to its average volume of 6,655,522. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $267.60 billion, a price-to-earnings ratio of 19.03, a PEG ratio of 1.37 and a beta of 0.56. The company has a fifty day simple moving average of $448.25 and a 200 day simple moving average of $501.48.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the business posted $6.91 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John H. Noseworthy bought 300 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the transaction, the director now directly owns 6,063 shares of the company's stock, valued at $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.33% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on UNH. Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Oppenheimer lowered their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.